James O'Brien

James O'Brien

Director Financiero/CFO en MESOBLAST LIMITED .
59 años
Health Technology
Commercial Services
Consumer Services

Perfil

James M.
O'Brien
is currently Chief Financial Officer at Mesoblast Ltd. since 2025.
Former positions include Chief Financial Officer at Faron Pharmaceuticals Oy from 2023 to 2024, Chief Financial Officer at Cognition Therapeutics, Inc. from 2019 to 2022, Executive Vice President-Finance at Enzo Biochem, Inc. from 2014 to 2019, Vice President & Corporate Controller at Allergan UC from 2010 to 2013, Vice President at Takeda Pharmaceutical Co., Ltd. in 2010, Chief Accounting Officer at U.S.I.
Holdings Corp.
from 2008 to 2009, Vice President & Controller at Aptuit LLC from 2005 to 2007, Chief Accountant at Purdue Pharma LP, and Principal at both Bristol Myers Squibb Co. and PricewaterhouseCoopers LLP.
Education includes undergraduate studies at George Washington University and an MBA from Fordham University.

Cargos activos de James O'Brien

EmpresasCargoInicio
MESOBLAST LIMITED Director Financiero/CFO 17/11/2025

Antiguos cargos conocidos de James O'Brien.

EmpresasCargoFin
FARON PHARMACEUTICALS OY Director Financiero/CFO 15/04/2024
COGNITION THERAPEUTICS, INC. Director Financiero/CFO 12/08/2022
ENZO BIOCHEM, INC. Corporate Officer/Principal 03/11/2019
ALLERGAN PLC Comptroller/Controller/Auditor -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/08/2010
Ver el detalle de la experiencia de James O'Brien.

Formación de James O'Brien.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

28

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Health Technology

Consumer Services

Distribution Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology